http://www.ms-network.com/newsflash/show.asp?ID=216
19 June 2001
New treatments for MS are constantly
being tested in clinical trials, and many patients pay close attention
their results, hoping to learn about the latest medication that will change
their lives. But the data from these trials is easy to misinterpret, and
this can lead to unnecessary fears or false hopes.
Hosted by David R. Marks, MD , WVIT-TV,
Connecticut (NBC), this webcast features Frederick Munschauer, MD ; State
University of New York, Buffalo and Jeffrey Greenstein, MD ; Temple University
School of Medicine, PA, who will cover topics such as:
A videobroadcast recorded live on
April 5, 2001 discusses how to interpret clinical trial data.
What is a prospective, double-blinded,
placebo-controlled trial?